Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tandem Diabetes Care (TNDM) Share-based Compensation (2016 - 2025)

Historic Share-based Compensation for Tandem Diabetes Care (TNDM) over the last 13 years, with Q3 2025 value amounting to $21.1 million.

  • Tandem Diabetes Care's Share-based Compensation fell 1955.79% to $21.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $100.4 million, marking a year-over-year increase of 466.77%. This contributed to the annual value of $101.4 million for FY2024, which is 1510.85% up from last year.
  • According to the latest figures from Q3 2025, Tandem Diabetes Care's Share-based Compensation is $21.1 million, which was down 1955.79% from $25.6 million recorded in Q2 2025.
  • In the past 5 years, Tandem Diabetes Care's Share-based Compensation registered a high of $28.2 million during Q4 2024, and its lowest value of $12.9 million during Q1 2021.
  • Moreover, its 5-year median value for Share-based Compensation was $22.0 million (2024), whereas its average is $21.4 million.
  • In the last 5 years, Tandem Diabetes Care's Share-based Compensation soared by 4293.82% in 2022 and then plummeted by 1955.79% in 2025.
  • Quarter analysis of 5 years shows Tandem Diabetes Care's Share-based Compensation stood at $17.1 million in 2021, then surged by 42.94% to $24.4 million in 2022, then decreased by 6.96% to $22.7 million in 2023, then rose by 23.86% to $28.2 million in 2024, then fell by 24.94% to $21.1 million in 2025.
  • Its last three reported values are $21.1 million in Q3 2025, $25.6 million for Q2 2025, and $25.5 million during Q1 2025.